Space LiinTech (CEO Hak-soon Yoon), a space medicine company, announced on the 9th that it signed a memorandum of understanding (MOU) with Yonsei University College of Medicine for cooperation in space medicine research and space environment-based experiments.
This agreement aims to establish a foundation for industry-academia collaboration that combines space-based bio-pharmaceutical research with medical research capabilities to build a sophisticated research system. The two organizations plan to leverage the strengths of space experimental platforms and medical research sites to ensure that space-based joint research leads to tangible results.
Spacelintech will support joint research based on its space environment experiment platform and space demonstration infrastructure operations, while Yonsei University College of Medicine will leverage its medical and clinical research capabilities to collaborate to ensure that space-based research translates into medical value. This collaboration is also expected to foster a space medicine workforce prepared for the new space era.
Yoon Hak-soon, CEO of Spacelintech, said, “Our collaboration with Yonsei University College of Medicine is an important opportunity to expand space environment-based research beyond the experimental level to a reproducible research system.” He added, “We will strengthen our cooperation to create meaningful research results by combining the expertise of both institutions and to help Korea’s space medicine research capabilities leap forward to a global level.”
Choi Jae-young, Dean of Yonsei University College of Medicine, said, “Medical research utilizing the space environment has great potential to lead to new medical technologies,” and added, “Through collaboration with Spacelintech, we will discover research topics in space medicine and strive to expand them into innovative medical technologies.”
Spacelintech recently conducted a demonstration of its space pharmaceutical research module, "BEE-PC1," on the International Space Station (ISS), accumulating experience in automated protein crystallization experiments in space environments. Following this, the company also established a satellite-based protein pharmaceutical crystallization research system with the launch of its space bio research satellite, "BEE-1000." This year, Spacelintech plans to leverage this demonstration experience to conduct joint research with medical institutions, identifying research topics with high potential for medical applications and producing tangible results.
You must be logged in to post a comment.